Supernus Pharmaceuticals
SUPN
#4515
Rank
NZ$2.86 B
Marketcap
$51.93
Share price
0.91%
Change (1 day)
9.28%
Change (1 year)

EPS for Supernus Pharmaceuticals (SUPN)

EPS in 2023 (TTM): $1.26

According to Supernus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $1.28. In 2022 the company made an earnings per share (EPS) of $1.83 an increase over its 2021 EPS that were of $1.65.

EPS history for Supernus Pharmaceuticals from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.26-31.24%
2022$1.8310.78%
2021$1.65-57.68%
2020$3.9012.09%
2019$3.480.47%
2018$3.4689.38%
2017$1.83-38.59%
2016$2.97534.48%
2015$0.47-211.54%
2014-$0.42-91.1%
2013-$4.7239.46%
2012-$3.38-69.27%
2011-$11.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$31.23 2,345.57%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.78 587.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.42 402.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.80 276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.77 1,682.95%๐Ÿ‡บ๐Ÿ‡ธ USA